Aphria goes beyond the foundation regulatory requirements to ensure we provide safe, consistent, and effective medical cannabis products.
Patient completes Aphria's registration package.
Physician completes the medical document. This outlines the number of prescribed grams per day, duration of the prescription, and any THC limits.
Your patient will be registered and contacted by our Patient Care Team within 48 hours.
Your patient may place an order through their online account or over the phone.
To request an Aphria Product Guide for Health Professionals, contact our Medical Education department: email@example.com
The Government of Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) establish the legal framework that enables patients to obtain authorization to possess dried marijuana for medical purposes. Under these regulations, physicians have primary responsibility for the decision to authorize patient use of dried marijuana for medical purposes.
The Access to Cannabis for Medical Purposes Regulations (ACMPR) came into force in August 2016. The regulations set out a framework for commercial production by licensed producers responsible for the production and distribution of quality-controlled fresh or dried marijuana or cannabis oil or starting materials (i.e., marijuana seeds and plants) in secure and sanitary conditions. The regulations also set out provisions for individuals to produce a limited amount of cannabis for their own medical purposes or to designate someone to produce it for them. Transitional provisions, consequential amendments, and provisions are also included.
This document has been prepared by the Controlled Substances and Tobacco Directorate at Health Canada to provide information on the use of cannabis and cannabinoids for medical purposes.
When considering the use of cannabis for medical purposes, it is understandable that patients and healthcare practitioners may have questions regarding dosage and daily amounts of cannabis for specific medical conditions. The following information has been prepared to provide patients and healthcare practitioners with information related to daily amounts and dosing.
Created by Aphria, this document assists health professionals in understanding the differences between dried cannabis and cannabis oil.
The only legal access to medical cannabis in Canada is through Health Canada Licensed Producers, such as Aphria. Some Canadians still have personal production licenses, which grant them authorization to produce medical cannabis for personal use.
No, there is no additional license required to prescribe medical cannabis. The Access to Cannabis for Medical Purposes Regulations (ACMPR) designate medical practitioners and nurse practitioners with prescribing privileges. However, nurse practitioners should consult with their College to determine their recommendations to prescribing medical cannabis.
The product selection process may involve some trial and error. Patients who are new to medical cannabis should “start low and go slow”, in other words, start with strains that are low in THC and increase gradually, as needed. Aphria’s knowledgable Patient Care Team is available to patients for strain selection guidance.
Cannabis oil products allow for more precise and controlled dosing, this option may be ideal for novice patients. Cannabis oil can be applied directly under the tongue or incorporated into an edible, whereas dried cannabis may be vaporized, smoked, or incorporated into an edible or tea. Along with the differing ingestion methods, cannabis oil is processed by the body differently than dried cannabis. This results in a gradual onset of effects in comparison to smoking or vaporizing dried cannabis. Patients report experiencing the effects of cannabis oil for a longer duration than smoked or vaporized dried cannabis.
Each patient receives an informational package with their first order. Within this package is Aphria’s Medical Journal, designed to assist patients with strain selection and tracking symptom management progress. We encourage patients to bring their Medical Journal to all follow-up appointments.
Under Health Canada regulations, patients will receive their medication by a courier service that ensures the tracking and safekeeping of the package during transportation. The destination may include the patient’s home address, their Health Care Practitioner’s address, or in the case of an individual who is responsible for the patient, the shipping address specified in the caregiver’s registration document.
Currently, medical cannabis is not covered by most insurance plans. However, medical cannabis may be claimed as a medical expense for tax purposes.